Position in BBIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$71,485,868
+$23,593,797 QoQ
Shares Held
962,643
+53.7% QoQ
Ownership
0.491%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GW&K Investment Management, LLC holds $699,704,251 across 25 Biotechnology names. BBIO ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
623,048 | $101,880,808 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,393,875 | $90,086,140 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
This page
|
962,643 | $71,485,868 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
371,098 | $70,156,076 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,618,686 | $58,790,674 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
779,349 | $58,521,315 | |
| 7 | VCEL |
Vericel Corp
|
1,616,855 | $52,014,225 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,214,901 | $41,100,100 |
All Filings in BBIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $71,485,868 | 962,643 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $47,892,071 | 626,122 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $31,072,429 | 598,237 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||